Connection

AMY CLARK HESSEL to CD8-Positive T-Lymphocytes

This is a "connection" page, showing publications AMY CLARK HESSEL has written about CD8-Positive T-Lymphocytes.
Connection Strength

0.102
  1. Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8+ Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results. Clin Cancer Res. 2020 07 01; 26(13):3211-3219.
    View in: PubMed
    Score: 0.102
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.